Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/임상시험 PDS Biotech to Pursue Pivotal Trial in HNSCC After Exciting Phase II Results 11-17-2023
Novo Nordisk Launches Combo Trial of Pipeline Drug CagriSema versus Eli Lilly’s Newly Approved Zepbound 11-17-2023
Post Hoc Analysis of SCORED Trial Sheds Positive Light on Inpefa for Heart Failure 11-17-2023
Positive Phase III Data Could Help Position Ubrelvy in a Crowded Migraine Market 11-20-2023
AstraZeneca’s Imfinzi Phase III Trial Raises Trial Design Questions 11-21-2023
Truqap’s First Approval Is Not What AstraZeneca Was Hoping for 11-22-2023
Roche Attempts to Expand in the Lupus Nephritis Treatment Landscape with an Oncology Drug After Promising Phase II Trials 11-22-2023
VPAS Is Dead, Long Live VPAG—Could the UK’s New Clawback Revision Save the Day 11-27-2023
Where do Anti-Tumor Necrosis Factor Like Cytokine Agents go After Their Initial Excitement? 11-30-2023
BioPharmaceutical Outsourcing Report 11-30-2023
Madrigal Ramps Up Preparations for Commercial Launch of Resmetirom in NASH 11-30-2023
Waning Focus on Stimulant Abuse Potential Could Negatively Affect Pipeline Non-stimulants 11-30-2023
Partnership Deals for Psychedelic Drugs Take a Trip with 500% Surge in 2023 12-01-2023
질환별 Experts Believe Gene Therapy Offers Potential to Impact Gaucher Disease Market 11-21-2023
World AIDS Day 2023 Highlights Community Leadership to End the HIV Epidemic 12-01-2023
컨퍼런스/심포지엄/학회 CPHI Barcelona: A Tough Funding Environment Necessitates Integration and Flexibility for ATMP Manufacturing 11-24-2023
The Movement Towards Trial Transparency 11-29-2023

 

 

 

○ 공고기간 : 2022. 10. 11.(화) ~ 11. 15.(화)
○ 소재지 : 보건산업혁신창업센터 * 서울역인근, 서울특별시중구칠패로36 봉래빌딩3층
○ 선정규모 : 19개 기업 내외 * 독립형(2인) 1개사, 독립형(1인) 2개사, 오픈형 16개사
○ 모집목적
- 기술과 사업성은 있으나 사업장 확보에 어려움이 있는 예비 창업자 및 창업기업을 대상으로 비즈니스 네트워크 연계 및 사무공간 제공 으로 스타기업 발굴 육성
○ 모집대상
- 신청자격: 의약품, 의료기기, 디지털 헬스케어 등 바이오 의료 분야에서 기술기반 창업을 준비하는 예비창업자 및 창업 3년 이내 초기창업기업

구분 주요 내용

지원 자격

- 예비창업자 : 선정 후 1년 이내에 사업자 등록 가능한자
* 사업 공고일까지 창업경험이 없거나, 대표자 명의의 사업자 등록(개인, 법인)이 없는 자
- 창업기업 : 공고일 기준 창업 후 3년(36개월) 이내 설립된 기업
* 창업일 기준 : 개인사업자–사업개시일(사업자등록증 기준), 법인사업자–

법인설립등기일(법인등기부등본 기준)

* 최대 2년(기본 1년, 연장평가 결과에 따라 1년 연장 가능) 지원 가능
* 예비창업자: 재평가 시, 선정 후 1년 이내에 사업자 등록 여부 반영

[공고문] 2022년 혁신창업멤버스 모집 연장 공고.pdf
0.43MB

+ Recent posts